Sign commercial terms the operation can actually perform.

Who this is for

Pharmaceutical, biotechnology, medical-device, diagnostics and digital-health companies

Typically instructed by: Regional and country legal counsel · legal business partners · commercial · market access · technology and data

Scope

What can be instructed

Distribution and supply

Distribution, supply, agency and wholesale arrangements, including territory, exclusivity, forecasting, minimum volumes and termination.

Licensing

In-licensing and out-licensing, field and territory definition, sublicensing, improvements and royalty mechanics.

Manufacturing and technology transfer

Contract manufacturing, fill-finish and technology-transfer arrangements, including the transfer package, process ownership, capacity commitments and what happens on exit.

Services and outsourcing

Research, clinical, laboratory, logistics and commercial-services agreements, including subcontracting, service levels and the consequences of failure to meet them.

Software, SaaS and digital health

Software licensing, SaaS and platform terms, connected devices and digital-health arrangements, including availability commitments, support, security obligations and exit and continuity.

Data

Ownership, access and permitted use of study, clinical, patient and operational data, cross-border transfer, and the processing terms that accompany the commercial arrangement.

Quality and pharmacovigilance

Quality agreements and pharmacovigilance agreements, and their alignment with the underlying commercial contract.

Product liability and recalls

Liability allocation, recall responsibility and cost-bearing, and the interaction with insurance.

Regulatory dependencies in commercial terms

How approval timing, licensing and labelling requirements are reflected in supply commitments, launch dates, minimum volumes and pricing mechanics, so that the contract does not oblige performance the regulatory position cannot yet support.

Where a matter turns on patent scope or prosecution, the firm coordinates patent counsel rather than advising on it directly. Where the market-entry structure or the allocation of regulatory responsibility is still open, that is addressed under Regulatory and market access.

Before you instruct

What helps the firm assess the matter

• The counterparties and any related entities, for the conflicts check.
• The product, service or platform, and its South African regulatory status if relevant.
• Whether a global template governs, and which terms are negotiable.
• The commercial deadline the arrangement is working to.

Free tool

Before you instruct, work through the checklist

Use the South Africa market-entry checklist: the entity, authorisation and route-to-market steps to sequence before launch.